PATENT CLAIM ANALYSIS

Application Number: 16079812
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-03
Patent Classification: ["546", "153000"]

Abstract:
The present invention relates to compounds of formula (I) including any stereochemically isomeric form thereof, or pharmaceutically acceptable salts thereof, for the treatment of tuberculosis.

Claim (Index 22):
The compound according to  claim 1 , wherein R 5  is bromine.

Metadata:
- Claim Count in Document: 74.0
- Percentile: 96.0
- Lexical Diversity: 1.11111
- Patent Class: 546.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15325824', '15112294', '11219148', '11015508', '15311817']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7675776908759356
- 35 USC 102 Novelty (BERT): 0.512876502514903
- Combined Prediction Score: 0.7421075720398324
- Mean Citation Score: 244.50118200000003
- Max Citation Score: 264.78528
- Similarity Product: 179.27503455265045

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test